Image Results
No matches found.
Video Results
No matches found.
Web Results
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next | Last
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain ... (Search Map)
Cilengitide (EMD 121974) inhibits two receptor proteins (proteins on cell ... evaluated by Gd MRI within 2 weeks prior to the first dose of EMD 121974. ...
Definition of EMD 121974 - NCI Dictionary of Cancer Terms (Search Map)
The search textbox has an autosuggest feature. ... EMD 121974. A substance that is being studied as an anticancer and antiangiogenesis drug. ...
Page 1 of 3 (Search Map)
"A Phase II Evaluation of EMD 121974 (NSC 707544, Cilengitide) in Patients ... associated with EMD 121974 therapy in patients with non-metastatic androgen-independent ...
EMD 121974 in Treating Patients With Advanced Solid Tumors - Full Text ... (Search Map)
RATIONALE: EMD 121974 may slow the growth of solid tumors by stopping blood flow ... Patients receive EMD 121974 IV over 1 hour twice weekly. ...
Page 1 of 3 (Search Map)
"A Phase II Evaluation of EMD 121974 (NSC 707544, Cilengitide) in Patients ... associated with EMD 121974 therapy in patients with non metastatic androgen independent ...
Clinical Trials (PDQ®) - National Cancer Institute (Search Map)
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer ... Patients receive EMD 121974 IV over 1 hour twice weekly for 4 weeks. ...
EMD 121974 in Treating Patients With Locally Advanced or Metastatic ... (Search Map)
Purpose RATIONALE: EMD 121974 may stop the growth of cancer by stopping blood flow to the tumor. ... Patients receive EMD 121974 IV over 1 hour twice weekly ...
MDACC Study Summary 2003-0988 (Archived) (Search Map)
A Phase 2 Study of EMD 121974 (Cilengitide, NSC 707544) in Patients with Metastatic Melanoma ... To determine the overall survival in patients who receive EMD 121974 ...
NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction ... (Search Map)
Background: EMD 121974 (cilengitide) is a selective integrin receptor inhibitor ... Conclusions: EMD 121974 (cilengitide) is well-tolerated when combined with ...
Cancer 411 (Search Map)
Phase I Study of Cilengitide (EMD 121974) in Patients With Advanced Solid Tumors ... TREATMENT: Patients will receive a 4-week continuous infusion of EMD 121974. ...
